RxDoctor Payments Data

Manish Jotwani, MD

Nephrology · Flushing, NYNPI 1942277173

Payments from drug & device makers

$34,603in general payments, 2019–2025

Across 38 payments — averaging $910.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AV Medical Technologies Ltd.$21K
  • Medtronic$13K
  • Bard Peripheral Vascular, Inc.$433
  • Otsuka America Pharmaceutical, Inc.$168
  • Amarin Pharma, Inc.$125
  • Lemaitre Vascular, Inc.$31
  • plus $45 from 3 others

What the payments were for

  • Royalty or licence$12,49736%
  • Consulting fees$20,50059%
  • Food & beverage$1,6065%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AV Medical Technologies Ltd.2$20,500
Medtronic(2 entities)18$13,301
Bard Peripheral Vascular, Inc.9$433
Otsuka America Pharmaceutical, Inc.4$168
Amarin Pharma, Inc.1$125
Lemaitre Vascular, Inc.1$31
Covidien LP1$22
Novo Nordisk1$17
Avenu Medical Inc.1$5

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$34,603 in reported general payments places this provider in the 85th percentile of 935 nephrology providers in New York.

See all nephrology providers in New York

Medicare billing

Part B allowed, 2024
$159,220
Medicare patients
226
Services billed
1,129

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone36$164

Paid to pharmacies, not to this prescriber.

Other nephrology in Flushing

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →